Invivydincis A Biopharmaceutical Company Based In Walthammassachusettsfocused On Developing Innovative Antibody Based Therapies For Serious Viral Infectious Diseasesoriginally Founded As Adagio Therapeuticsincin 2020The Company Rebranded To Invivydincin September 2022 And Is Publicly Traded On The Nasdaq Under The Ticker Symbol Ivvd The Company Specializes In The Discoverydevelopmentand Commercialization Of Antibody Therapies Using A Proprietary Technology Platformthis Platformknown As Invymabintegrates Viral Surveillance And Predictive Modeling With Advanced Antibody Engineering To Create Therapies That Are More Effective And Resilient Against Viral Evolutionkey Products Include Pemgardaan Investigational Monoclonal Antibody For Covid 19 Preventionand Other Candidates In Various Stages Of Development Targeting Covid 19 And Seasonal Influenzainvivyd Is Dedicated To Protecting Vulnerable Populations And Improving Lives Through Its Robust Pipeline Of Monoclonal Antibody Candidates
No conferences found for this company.
| Company Name | Adagio Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
